AI in Clinical Development: A Global Primer on Regulatory Expectations

As Artificial Intelligence (AI) becomes increasingly embedded in clinical development and regulatory processes, global health authorities have responded with a range of evolving guidelines to ensure safety, transparency, data privacy, and compliance. From optimizing trial design and accelerating patient recruitment to generating insights in regulatory submissions, AI holds transformative potential but also introduces novel regulatory challenges.